drugset
Drugs / Perlatte
last change Nov 2018 re-read 3 minutes ago

Perlatte

Protein / enzyme biologic

Developed for
lactose intolerance
Investigated by
Eurofarma Laboratorios S.A.

Trials 1

today NCT01145586 · Ph 3
20112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT01145586 Jun 2011 → Mar 2012 lactose intolerance Eurofarma Laboratorios S.A. Completed Met primary

Press releases naming this drug 1 release

DateIssuerRelease
2018-11-19 Eurofarma Laboratorios S.A. Campanha de Perlatte®, da Eurofama, recebe prêmios publicitários eurofarma.com.br ↗

Evidence & citations 4 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Perlatte “receive the experimental product (Perlatte(r) - Eurofarma Laboratórios S.A.) or the reference product (Lactaid(r) - McNeilNutritionals, USA) orally (one tablet, three times per...” PMID 27706451 ↗ Oct 2016
Action Restore “The experimental product was non-inferior to the reference product, indicating that it was an effective replacement therapy for endogenous lactase in lactose intolerance patients.” PMID 27706451 ↗ Oct 2016
Modality Protein / enzyme biologic “Evaluate the efficacy of a product containing exogenous lactase in tablet form compared to a reference product with proven effectiveness in patients with lactose intolerance.” PMID 27706451 ↗ Oct 2016
Route Oral “orally (one tablet, three times per day)” PMID 27706451 ↗ Oct 2016